Form 4 for DBVT DBV Technologies S.A.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001415889-24-027648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-25 | 2024-11-21 | DBVT | Mohideen Pharis | Chief Medical Off | A - Grant | $0.00 | +35.0K | 114.4K | +44% | $0 |
| D | 2024-11-25 | 2024-11-21 | DBVT | Mohideen Pharis | Chief Medical Off | S - Sale | $0.54 | -2,350 | 112.0K | -2% | -$1,269 |
| D | 2024-11-25 | 2024-11-21 | DBVT | Mohideen Pharis | Chief Medical Off | A - Grant | $0.00 | +215.0K | 215.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-21 | A | A | 35,000 | $0.00 | 114,367 | D | — | — | (F1) The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share. |
| 2 | Common | Ordinary Shares | 2024-11-21 | S | D | 2,350 | $0.54 | 112,017 | D | — | — | (F1) The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share. (F4) This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0546 to EURO 1.00 as of November 21, 2024. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-11-21 | A | A | 215,000 | $0.00 | 215,000 | D | $0.75 · — to 2034-11-21 | 215,000 Ordinary Shares | (F4) This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0546 to EURO 1.00 as of November 21, 2024. (F5) The option shall vest in four equal annual installments commencing on November 21, 2025, subject to the Reporting Person continuing to provide service through each such date. |